Background/Aims: Leptin may be an important link between obesity and many high-burden diseases, including cancer and cardiovascular disease, but leptin levels and correlates in individuals of diverse racial backgrounds have not been well characterized despite racial differences in incidence and mortality patterns for many obesity-related diseases. Methods: In a cross-sectional study of 915 white and 892 black women enrolled in the Southern Community Cohort Study (age 40–79 years, half postmenopausal), serum leptin levels were compared between the race groups and across categories of body mass index (BMI). Potential correlates of leptin were assessed via race-stratified linear regression models. Results: Blacks had higher unadjusted leptin levels than whites (geometric mean 22.4 vs. 19.0 ng/ml; p < 0.0001). Leptin increased with increasing BMI, and racial differences in leptin were most pronounced in women with BMI ≥25. Significant correlates of leptin included BMI, age, alcohol consumption, cigarette smoking, diabetes (both races) and fat consumption (black women only). Leptin remained higher in black women (22.7 vs. 18.8 ng/ml) after adjustment for these factors. Conclusions: Persistent racial differences in leptin concentrations exist after adjustment for BMI and other factors. Leptin assessment may be informative in future studies that investigate racial differences in the development of obesity-related diseases.

Keywords:
Leptin, Body mass index, Race, Adipokines
1.
Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM: Positional cloning of the mouse obese gene and its human homologue. Nature 1994;372:425–432.
2.
Anubhuti, Arora S: Leptin and its metabolic interactions: an update. Diabetes Obes Metab 2008;10:973–993.
3.
Koerner A, Kratzsch J, Kiess W: Adipocytokines: leptin – the classical, resistin – the controversical, adiponectin – the promising, and more to come. Best Pract Res Clin Endocrinol Metab 2005;19:525–546.
4.
van Kruijsdijk RC, van der Wall E, Visseren FL: Obesity and cancer: the role of dysfunctional adipose tissue. Cancer Epidemiol Biomarkers Prev 2009;18:2569–2578.
5.
Ries LAG, Harkins D, Krapcho M, Mariotto A, Miller BA, Feuer EJ, Clegg L, Eisner MP, Horner MJ, Howlader N, Hayat M, Hankey BF, Edwards BK (eds). SEER Cancer Statistics Review, 1975-2003. Bethesda, National Cancer Institute. http://seer.cancer.gov/csr/1975_2003/, based on November 2005 SEER data submission, posted to the SEER web site, 2006.
6.
Centers for Disease Control and Prevention (CDC): Differences in prevalence of obesity among black, white, and Hispanic adults – United States, 2006–2008. MMWR Morb Mortal Wkly Rep 2009;58:740–744.
7.
Signorello LB, Hargreaves MK, Steinwandel MD, Zheng W, Cai Q, Schlundt DG, Buchowski MS, Arnold CW, McLaughlin JK, Blot WJ: Southern community cohort study: establishing a cohort to investigate health disparities. J Natl Med Assoc 2005;97:972–979.
8.
Hargreaves MK, Arnold C, Blot WJ: Community health centers: their role in the treatment of minorities and in health disparities research; in Satcher D, Pamies R, (eds): Multicultural Medicine and Health Disparities. New York, McGraw-Hill, 2006, pp 485–494.
9.
Signorello LB, Munro HM, Buchowski MS, Schlundt DG, Cohen SS, Hargreaves MK, Blot WJ: Estimating nutrient intake from a food frequency questionnaire: incorporating the elements of race and geographic region. Am J Epidemiol 2009;170:104–111.
10.
Buchowski MS, Schlundt DG, Hargreaves MK, Hankin JH, Signorello LB, Blot WJ: Development of a culturally sensitive food frequency questionnaire for use in the Southern Community Cohort Study. Cell Mol Biol (Noisy-le-grand) 2003;49:1295–1304.
11.
Kleinbaum DG, Kupper LL: Applied Regression Analysis and Other Multivariable Methods. North Scituate, Duxbury Press, 1978.
12.
Akaike H: Fitting autoregressive models for prediction. Ann Inst Stat Math 1969;21:243–247.
13.
Donahue RP, Zimmet P, Bean JA, Decourten M, DeCarlo Donahue RA, Collier G, Goldberg RB, Prineas RJ, Skyler J, Schneiderman N: Cigarette smoking, alcohol use, and physical activity in relation to serum leptin levels in a multiethnic population: the Miami Community Health Study. Ann Epidemiol 1999;9:108–113.
14.
Perry HM 3rd, Morley JE, Horowitz M, Kaiser FE, Miller DK, Wittert G: Body composition and age in African-American and Caucasian women: relationship to plasma leptin levels. Metabolism 1997;46:1399–1405.
15.
Nicklas BJ, Toth MJ, Goldberg AP, Poehlman ET: Racial differences in plasma leptin concentrations in obese postmenopausal women. J Clin Endocrinol Metab 1997;82:315–317.
16.
DeLellis Henderson K, Rinaldi S, Kaaks R, Kolonel L, Henderson B, Le Marchand L: Lifestyle and dietary correlates of plasma insulin-like growth factor binding protein-1 (IGFBP-1), leptin, and C-peptide: the Multiethnic Cohort. Nutr Cancer 2007;58:136–145.
17.
Ruhl CE, Everhart JE, Ding J, Goodpaster BH, Kanaya AM, Simonsick EM, Tylavsky FA, Harris TB; Health, Aging, and Body Composition Study: Serum leptin concentrations and body adipose measures in older black and white adults. Am J Clin Nutr 2004;80:576–583.
18.
Schmidt MI, Duncan BB, Vigo A, Pankow JS, Couper D, Ballantyne CM, Hoogeveen RC, Heiss G; ARIC Investigators: Leptin and incident type 2 diabetes: risk or protection? Diabetologia 2006;49:2086–2096.
19.
Ruhl CE, Everhart JE: Leptin concentrations in the United States: relations with demographic and anthropometric measures. Am J Clin Nutr 2001;74:295–301.
20.
Kanaley JA, Giannopoulou I, Tillapaugh-Fay G, Nappi JS, Ploutz-Snyder LL: Racial differences in subcutaneous and visceral fat distribution in postmenopausal black and white women. Metabolism 2003;52:186–191.
21.
Wagner DR, Heyward VH: Measures of body composition in blacks and whites: a comparative review. Am J Clin Nutr 2000;71:1392–1402.
22.
Hube F, Lietz U, Igel M, Jensen PB, Tornqvist H, Joost HG, Hauner H: Difference in leptin mRNA levels between omental and subcutaneous abdominal adipose tissue from obese humans. Horm Metab Res 1996;28:690–693.
23.
Montague CT, Prins JB, Sanders L, Digby JE, O’Rahilly S: Depot- and sex-specific differences in human leptin mRNA expression: implications for the control of regional fat distribution. Diabetes 1997;46:342–347.
24.
Willett WC: Nutritional Epidemiology, ed 2. New York, Oxford University Press, 1998.
25.
De Silva A, De Courten M, Zimmet P, Nicholson G, Kotowicz M, Pasco J, Collier GR: Lifestyle factors fail to explain the variation in plasma leptin concentrations in women. Nutrition 1998;14:653–657.
26.
Wei M, Stern MP, Haffner SM: Serum leptin levels in Mexican Americans and non-Hispanic whites: association with body mass index and cigarette smoking. Ann Epidemiol 1997;7:81–86.
27.
Marques-Vidal P, Bochud M, Paccaud F, Mooser V, Waeber G, Vollenweider P: Distribution of plasma levels of adiponectin and leptin in an adult Caucasian population. Clin Endocrinol (Oxf) 2010;72:38–46.
28.
Ganji V, Kafai MR, McCarthy E: Serum leptin concentrations are not related to dietary patterns but are related to sex, age, body mass index, serum triacylglycerol, serum insulin, and plasma glucose in the US population. Nutr Metab (Lond) 2009;6:3.
29.
Panarotto D, Ardilouze JL, Tessier D, Maheux P: The degree of hyperinsulinemia and impaired glucose tolerance predicts plasma leptin concentrations in women only: a new exploratory paradigm. Metabolism 2000;49:1055–1062.
30.
Sinha MK, Sturis J, Ohannesian J, Magosin S, Stephens T, Heiman ML, Polonsky KS, Caro JF: Ultradian oscillations of leptin secretion in humans. Biochem Biophys Res Commun 1996;228:733–738.
31.
Gorber SC, Tremblay M, Moher D, Gorber B: A comparison of direct vs. self-report measures for assessing height, weight and body mass index: a systematic review. Obes Rev 2007;8:307–326.
32.
Craig BM, Adams AK: Accuracy of body mass index categories based on self-reported height and weight among women in the United States. Matern Child Health J 2009;13:489–496.
© 2012 S. Karger AG, Basel
2012
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.